Back to Results

Arcadia Biosciences Inc (RKDA)

Arcadia Biosciences, Inc. is a NASDAQ-listed common stock company focused on plant-based food and beverage products in the United States. The company also develops crop improvement technologies, with an emphasis on wheat, aimed at improving field performance and enhancing the value of crops as food ingredients. Its product lineup has included GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. Founded in 2002 and headquartered in Dallas, Texas, Arcadia Biosciences operates across both agricultural innovation and consumer food and beverage categories.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-RKDA
$0.90
30.7% Upside
Undervalued
$12 1,639.1% Upside
—
Bargain
Weak
—
—
—
0.0%
August 19, 2026
-0.2x
0.5x
0.3x
1.446 M
-2.215 M
0.0%
86.9%
-173.1
—
45.6%
Send a message
Valuation • Fair Value

Arcadia Biosciences Inc (NASDAQ-RKDA) Fair Value by Valuation Model

Compare the primary fair value estimate for Arcadia Biosciences Inc (NASDAQ-RKDA) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.90

Estimated upside of 30.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$0.90

Comparable-company valuation reference.

Analyst Price Target

$12 1,639.1% Upside

Current consensus analyst target, where available.

How to read these valuation models

Use this section to compare the primary fair value estimate for Arcadia Biosciences Inc (NASDAQ-RKDA) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Arcadia Biosciences Inc (NASDAQ-RKDA)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

4.758 M

Current operating scale indicator.

Revenue Forecast

7.7 M

Forward revenue estimate.

EBITDA

-4.782 M

Current operating profitability reference.

EBITDA Forecast

-3.748 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Arcadia Biosciences Inc (NASDAQ-RKDA) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Arcadia Biosciences Inc (NASDAQ-RKDA)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

2

Weak quality score that deserves closer review.

Beneish M-Score

-8.09

No elevated caution signal from this screen.

Altman Z-Score

-173.1

Lower score that deserves closer risk review.

FCF / Net Income

45.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Arcadia Biosciences Inc (NASDAQ-RKDA). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Arcadia Biosciences Inc (NASDAQ-RKDA)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 19, 2026

Days to Earnings

29

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Arcadia Biosciences Inc (NASDAQ-RKDA), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Arcadia Biosciences Inc (NASDAQ-RKDA) Stock Forecast & Technical Outlook

Review Arcadia Biosciences Inc (NASDAQ-RKDA) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Arcadia Biosciences Inc (NASDAQ-RKDA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Arcadia Biosciences Inc (NASDAQ-RKDA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Arcadia Biosciences Inc (NASDAQ-RKDA) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Arcadia Biosciences Inc (NASDAQ-RKDA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Arcadia Biosciences Inc (NASDAQ-RKDA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Arcadia Biosciences Inc (NASDAQ-RKDA)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Arcadia Biosciences Inc (NASDAQ-RKDA) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

Arcadia Biosciences Inc (NASDAQ-RKDA) Stock FAQ

Quick answers about Arcadia Biosciences Inc (NASDAQ-RKDA) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.90
Estimated upside 30.7%
Valuation Rating
Undervalued
Estimated upside of 30.7%
Analyst Target
$12 1,639.1% Upside
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for Arcadia Biosciences Inc (NASDAQ-RKDA) is $0.90. This implies an estimated upside of 30.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 30.7% versus the current market price.

The available analyst price target for Arcadia Biosciences Inc (NASDAQ-RKDA) is $12 1,639.1% Upside.

The current financial health read for Arcadia Biosciences Inc (NASDAQ-RKDA) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Arcadia Biosciences Inc (NASDAQ-RKDA) is August 19, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Arcadia Biosciences Inc (NASDAQ-RKDA) is -0.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Arcadia Biosciences Inc is 1.446 M.

The current enterprise value listed for Arcadia Biosciences Inc is -2.215 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Arcadia Biosciences Inc is NASDAQ-RKDA, and the stock is listed on NASDAQ.

Arcadia Biosciences Inc (NASDAQ-RKDA) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Arcadia Biosciences Inc is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Arcadia Biosciences Inc is 86.9%. Free float helps investors understand how much of the share base is available for public trading.

Similar Food Products Stocks on NASDAQ View more

Mondelez International Inc (MDLZ) Mondelez International Inc (MDLZ)
Kraft Heinz Co (KHC) Kraft Heinz Co (KHC)
Smithfield Foods Inc (SFD) Smithfield Foods Inc (SFD)
Pilgrims Pride Corp (PPC) Pilgrims Pride Corp (PPC)
Campbell’s Co (CPB) Campbell’s Co (CPB)
Cal-Maine Foods Inc (CALM) Cal-Maine Foods Inc (CALM)
Marzetti Co (MZTI) Marzetti Co (MZTI)
Freshpet Inc (FRPT) Freshpet Inc (FRPT)
J & J Snack Foods Corp (JJSF) J & J Snack Foods Corp (JJSF)
Mission Produce Inc (AVO) Mission Produce Inc (AVO)
Seneca Foods Corp A (SENEA) Seneca Foods Corp A (SENEA)
Seneca Foods Corp B (SENEB) Seneca Foods Corp B (SENEB)
Simply Good Foods Co (SMPL) Simply Good Foods Co (SMPL)
John B Sanfilippo & Son Inc (JBSS) John B Sanfilippo & Son Inc (JBSS)
Cresud SACIF y A (CRESY) Cresud SACIF y A (CRESY)
Mama’s Creations Inc (MAMA) Mama’s Creations Inc (MAMA)
Westrock Coffee Co (WEST) Westrock Coffee Co (WEST)
Vital Farms Inc (VITL) Vital Farms Inc (VITL)
Lifeway Foods Inc (LWAY) Lifeway Foods Inc (LWAY)
Oatly Group AB ADR (OTLY) Oatly Group AB ADR (OTLY)
Beyond Meat Inc (BYND) Beyond Meat Inc (BYND)
Alico Inc (ALCO) Alico Inc (ALCO)
CN Healthy Food Tech Group Corp (UCFI) CN Healthy Food Tech Group Corp (UCFI)
Forafric Global PLC (AFRI) Forafric Global PLC (AFRI)